SPI
PFE icon

Sutton Place Investors’s Pfizer PFE Stock Holding History

Sutton Place Investors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
8,626
-419
-5% -$11K 0.1% 147
2026
Q1 		$254K Sell
9,045
-910
-9% -$24.2K 0.14% 116
2025
Q4 		$248K Buy
9,955
+433
+5% +$10.9K 0.14% 115
2025
Q3 		$243K Sell
9,522
-137
-1% -$3.38K 0.14% 112
2025
Q2 		$234K Buy
9,659
+826
+9% +$19.3K 0.14% 109
2025
Q1 		$224K Buy
8,833
+472
+6% +$12.4K 0.15% 103
2024
Q4 		$222K Sell
8,361
-5,102
-38% -$138K 0.13% 122
2024
Q3 		$390K Buy
13,463
+747
+6% +$21.8K 0.24% 87
2024
Q2 		$356K Sell
12,716
-21,484
-63% -$591K 0.24% 83
2024
Q1 		$949K Buy
34,200
+6,343
+23% +$176K 0.47% 66
2023
Q4 		$802K Buy
+27,857
New +$842K 0.58% 58

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sutton Place Investors's PFE Position: Q2 2026 in Review

Sutton Place Investors reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $11K and leaving 8,626 shares worth $208K. The position accounts for 0.1% of the portfolio, ranked #147.

Sutton Place Investors first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $949K in Q1 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sutton Place Investors held 8,626 shares of Pfizer worth $208K as of Q2 2026.
  • Sutton Place Investors sold 419 Pfizer shares in Q2 2026, an estimated $11K.
  • Pfizer made up 0.1% of Sutton Place Investors's portfolio in Q2 2026, its #147 holding.
  • Sutton Place Investors first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Sutton Place Investors's Pfizer position peaked at $949K in Q1 2024.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sutton Place Investors's 13F filing for Q2 2026, filed 6 Aug 2026.